These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
420 related articles for article (PubMed ID: 28790389)
41. Inhibition of the Wnt-β-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy. Ma Y; Ren Y; Han EQ; Li H; Chen D; Jacobs JJ; Gitelis S; O'Keefe RJ; Konttinen YT; Yin G; Li TF Biochem Biophys Res Commun; 2013 Feb; 431(2):274-9. PubMed ID: 23291185 [TBL] [Abstract][Full Text] [Related]
42. Suppression of adriamycin resistance in osteosarcoma by blocking Wnt/β-catenin signal pathway. Wu BQ; Cao Y; Bi ZG Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3185-3192. PubMed ID: 28770967 [TBL] [Abstract][Full Text] [Related]
43. The anti-cancer activity of an andrographolide analogue functions through a GSK-3β-independent Wnt/β-catenin signaling pathway in colorectal cancer cells. Reabroi S; Saeeng R; Boonmuen N; Kasemsuk T; Saengsawang W; Suksen K; Zhu W; Piyachaturawat P; Chairoungdua A Sci Rep; 2018 May; 8(1):7924. PubMed ID: 29784906 [TBL] [Abstract][Full Text] [Related]
44. Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma. Cai Y; Mohseny AB; Karperien M; Hogendoorn PC; Zhou G; Cleton-Jansen AM J Pathol; 2010 Jan; 220(1):24-33. PubMed ID: 19882675 [TBL] [Abstract][Full Text] [Related]
45. FAM84B acts as a tumor promoter in human glioma via affecting the Akt/GSK-3β/β-catenin pathway. Wang M; Li C; Shi W Biofactors; 2021 Jul; 47(4):600-611. PubMed ID: 33759248 [TBL] [Abstract][Full Text] [Related]
46. Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis. Xu X; Zou L; Yao Q; Zhang Y; Gan L; Tang L Oncol Rep; 2017 Aug; 38(2):1035-1042. PubMed ID: 28627610 [TBL] [Abstract][Full Text] [Related]
47. Downregulation of tumor suppressing STF cDNA 3 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by the Wnt/GSK-3β/β-catenin/Snail signaling pathway. Lv YF; Dai H; Yan GN; Meng G; Zhang X; Guo QN Cancer Lett; 2016 Apr; 373(2):164-73. PubMed ID: 26845447 [TBL] [Abstract][Full Text] [Related]
48. Polyphyllin I induces G2/M phase arrest and apoptosis in U251 human glioma cells via mitochondrial dysfunction and the JNK signaling pathway. Liu J; Zhang Y; Chen L; Yu F; Li X; Dan Tao ; Zhao J; Zhou S Acta Biochim Biophys Sin (Shanghai); 2017 Jun; 49(6):479-486. PubMed ID: 28449039 [TBL] [Abstract][Full Text] [Related]
49. Inhibition of EZH2 via activation of SAPK/JNK and reduction of p65 and DNMT1 as a novel mechanism in inhibition of human lung cancer cells by polyphyllin I. Li L; Wu J; Zheng F; Tang Q; Wu W; Hann SS J Exp Clin Cancer Res; 2016 Jul; 35(1):112. PubMed ID: 27421653 [TBL] [Abstract][Full Text] [Related]
50. HOTAIR-mediated reciprocal regulation of EZH2 and DNMT1 contribute to polyphyllin I-inhibited growth of castration-resistant prostate cancer cells in vitro and in vivo. Xiang S; Zou P; Tang Q; Zheng F; Wu J; Chen Z; Hann SS Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):589-599. PubMed ID: 29221985 [TBL] [Abstract][Full Text] [Related]
51. Glycogen synthase kinase 3β promotes osteosarcoma invasion and migration via regulating PTEN and phosphorylation of focal adhesion kinase. Mai W; Kong L; Yu H; Bao J; Song C; Qu G Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 33969873 [TBL] [Abstract][Full Text] [Related]
52. Anticancer Effect of Polyphyllin I in Suppressing Stem Cell-Like Properties of Hepatocellular Carcinoma via the AKT/GSK-3 Liao M; Du H; Wang B; Huang J; Huang D; Tong G Oxid Med Cell Longev; 2022; 2022():4031008. PubMed ID: 36317061 [TBL] [Abstract][Full Text] [Related]
53. Silencing of galectin-3 represses osteosarcoma cell migration and invasion through inhibition of FAK/Src/Lyn activation and β-catenin expression and increases susceptibility to chemotherapeutic agents. Park GB; Kim DJ; Kim YS; Lee HK; Kim CW; Hur DY Int J Oncol; 2015 Jan; 46(1):185-94. PubMed ID: 25339127 [TBL] [Abstract][Full Text] [Related]
54. Noscapine targets EGFR He M; Jiang L; Ren Z; Wang G; Wang J Sci Rep; 2016 Nov; 6():37062. PubMed ID: 27830833 [TBL] [Abstract][Full Text] [Related]
55. Micafungin exerts antitumor effect on breast cancer and osteosarcoma through preventing EMT in tumor cells in an USP7/AKT/GSK-3β pathway-dependent manner. Wang QL; Wang L; Li QY; Li HY; Lin L; Wei D; Xu JY; Luo XJ Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4447-4459. PubMed ID: 38108838 [TBL] [Abstract][Full Text] [Related]
56. CYT997(Lexibulin) induces apoptosis and autophagy through the activation of mutually reinforced ER stress and ROS in osteosarcoma. Wang Z; Yin F; Xu J; Zhang T; Wang G; Mao M; Wang Z; Sun W; Han J; Yang M; Jiang Y; Hua Y; Cai Z J Exp Clin Cancer Res; 2019 Jan; 38(1):44. PubMed ID: 30704503 [TBL] [Abstract][Full Text] [Related]
57. The canonical Wnt-beta-catenin pathway in development and chemotherapy of osteosarcoma. Li C; Shi X; Zhou G; Liu X; Wu S; Zhao J Front Biosci (Landmark Ed); 2013 Jun; 18(4):1384-91. PubMed ID: 23747891 [TBL] [Abstract][Full Text] [Related]
58. MicroRNA-124 suppresses growth and aggressiveness of osteosarcoma and inhibits TGF-β-mediated AKT/GSK-3β/SNAIL-1 signaling. Yu B; Jiang K; Zhang J Mol Med Rep; 2018 May; 17(5):6736-6744. PubMed ID: 29488603 [TBL] [Abstract][Full Text] [Related]
59. The tumor suppressive role of RASSF1A in osteosarcoma through the Wnt signaling pathway. Wang WG; Chen SJ; He JS; Li JS; Zang XF Tumour Biol; 2016 Jul; 37(7):8869-77. PubMed ID: 26750098 [TBL] [Abstract][Full Text] [Related]
60. Oridonin inhibits the proliferation of human osteosarcoma cells by suppressing Wnt/β-catenin signaling. Liu Y; Liu YZ; Zhang RX; Wang X; Meng ZJ; Huang J; Wu K; Luo JY; Zuo GW; Chen L; Yin LJ; Deng ZL; He BC Int J Oncol; 2014 Aug; 45(2):795-803. PubMed ID: 24859848 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]